Wbh Advisory Inc Haemonetics Corp Transaction History

Wbh Advisory Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 27, 2021	SELL	$51.81 - $118.56 $99,008 - $226,568	-1,911 Closed	0 $0
Q4 2020 Jan 21, 2021	BUY	$88.75 - $119.95 $169,601 - $229,224	1,911 New	1,911 $238,000
Q1 2020 May 07, 2020	SELL	$74.34 - $121.82 $159,979 - $262,156	-2,152 Closed	0 $0
Q4 2019 Jan 27, 2020	SELL	$114.37 - $129.46 $6,862 - $7,767	-60 Reduced 2.71%	2,152 $247,000
Q3 2019 Oct 25, 2019	SELL	$117.16 - $138.52 $4,452 - $5,263	-38 Reduced 1.69%	2,212 $279,000
Q2 2019 Aug 02, 2019	BUY	$81.74 - $120.34 $183,915 - $270,765	2,250 New	2,250 $270,000
Q1 2019 Apr 22, 2019	SELL	$83.25 - $102.12 $196,470 - $241,003	-2,360 Closed	0 $0
Q3 2018 Oct 29, 2018	SELL	$89.96 - $114.58 $12,594 - $16,041	-140 Reduced 5.6%	2,360 $270,000
Q2 2018 Jul 31, 2018	BUY	$71.53 - $95.75 $178,825 - $239,375	2,500 New	2,500 $224,000

333

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.22B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Wbh Advisory Inc, based on Form 13F filings with the SEC.

Stay updated on Wbh Advisory Inc with notifications on news.